University well represented in Cure Cancer grants
7 February 2013
A group of 10 University of Sydney and affiliated medical institute cancer researchers have won a share in a record $3.2 million in grants awarded by the Cure Cancer Australia Foundation.
In 2013, the foundation is funding a total of 29 early-career cancer researchers who have received new grants to support their work of finding a cure for cancer. They join nine researchers who are being funded this year in their second year of Cure Cancer's two-year grants.
The University of Sydney and affiliated medical institute recipients are:
- Kimberley Beaumont, Centenary Institute of Cancer Medicine and Cell Biology
- Emily Colvin, Kolling Institute of Medical Research
- Angela Hong, Sydney Medical School, University of Sydney
- Richard Payne, Faculty of Science, University of Sydney
- Christopher Tomlinson, Children's Medical Research Institute
- Yu Zheng, ANZAC Research Centre
The continuing University of Sydney and affiliated medical institute grant recipients are:
- Rose Boutros, Children's Medical Research Institute
- Viive Howell, Kolling Institute (RNSH)
- Carolyn McNees, Children's Medical Research Institute
- Daniel Speidel, Children's Medical Research Institute
"Early career funding received from Cure Cancer provides a much needed start for researchers who go on to achieve wonderful, often world class, outcomes," CEO Cure Cancer Australia, Leanne Warner said.
"We're thrilled to be able to offer more grants to young researchers who we believe will deliver fresh, new thinking to find a cure for cancer. This substantial contribution to cancer research is a result of generous support from the Cure Cancer community including fundraisers, donors and corporate partners in addition to the popular fundraising and fitness program, Can Too."
"We are Australia's only charity whose sole focus is to fund talented scientists in the early years of their careers, when it is hard to compete for government funding with more established and experienced researchers."
Cure Cancer has funded many of today's research heavyweights. Past recipients have included Professor Robyn Ward who is now internationally recognised for her breakthrough work in identifying factors determining people at risk of developing bowel cancer, Professor Andrew Biankin who is currently the head of Pancreatic Cancer Research at the Garvan Institute of Medical Research, and Dr Catherine Suter currently Head of Epigenetics at the Victor Chang Cardiac Research Institute.
|Follow University of Sydney Media on Twitter|
Media enquiries: Rachel Gleeson, 0481 004 782, email@example.com